Noticias de ROIV_US
Noticias del mercado
Últimas noticias sobre ROIV_US — 201 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
Roivant Sciences Ltd. (ROIV) is up 3.7% today. Here is some analysis on what might have caused this
Roivant Sciences Ltd. (ROIV) ha subido un 3,7% hoy. Aquí hay un análisis sobre lo que podría haber causado esto.
Roivant Sciences (NASDAQ:ROIV) CEO Matthew Gline outlined the company’s priorities for the next 12 months, including the launch of LISRAYA, upcoming clinical data for brepocitinib and Immunovant’s IMVT-1402, and expansion of its pulmonary hypertension program. Gline said Roivant recently received a
Form 4 Roivant Sciences Ltd. For: 28 September By Investing.com
Página 4 de 11